Sage Therapeutics Statistics
Total Valuation
SAGE has a market cap or net worth of $581.13 million. The enterprise value is $168.20 million.
Important Dates
The next estimated earnings date is Wednesday, July 30, 2025, after market close.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SAGE has 62.62 million shares outstanding. The number of shares has increased by 2.08% in one year.
| Current Share Class | 62.62M |
| Shares Outstanding | 62.62M |
| Shares Change (YoY) | +2.08% |
| Shares Change (QoQ) | +0.97% |
| Owned by Insiders (%) | 0.44% |
| Owned by Institutions (%) | 77.11% |
| Float | 51.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.98 |
| Forward PS | 6.17 |
| PB Ratio | 1.42 |
| P/TBV Ratio | 1.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.13, with a Debt / Equity ratio of 0.03.
| Current Ratio | 9.13 |
| Quick Ratio | 8.78 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -63.53% and return on invested capital (ROIC) is -39.77%.
| Return on Equity (ROE) | -63.53% |
| Return on Assets (ROA) | -36.35% |
| Return on Invested Capital (ROIC) | -39.77% |
| Return on Capital Employed (ROCE) | -85.68% |
| Revenue Per Employee | $134,289 |
| Profits Per Employee | -$1.00M |
| Employee Count | 353 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.44% in the last 52 weeks. The beta is 0.18, so SAGE's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | -14.44% |
| 50-Day Moving Average | 7.36 |
| 200-Day Moving Average | 6.95 |
| Relative Strength Index (RSI) | 77.23 |
| Average Volume (20 Days) | 2,487,364 |
Short Selling Information
The latest short interest is 5.25 million, so 8.39% of the outstanding shares have been sold short.
| Short Interest | 5.25M |
| Short Previous Month | 5.20M |
| Short % of Shares Out | 8.39% |
| Short % of Float | 10.26% |
| Short Ratio (days to cover) | 7.37 |
Income Statement
In the last 12 months, SAGE had revenue of $47.40 million and -$354.40 million in losses. Loss per share was -$5.79.
| Revenue | 47.40M |
| Gross Profit | -138.35M |
| Operating Income | -359.78M |
| Pretax Income | -445.67M |
| Net Income | -354.40M |
| EBITDA | -358.98M |
| EBIT | -359.78M |
| Loss Per Share | -$5.79 |
Full Income StatementBalance Sheet
The company has $423.85 million in cash and $11.86 million in debt, giving a net cash position of $412.00 million or $6.58 per share.
| Cash & Cash Equivalents | 423.85M |
| Total Debt | 11.86M |
| Net Cash | 412.00M |
| Net Cash Per Share | $6.58 |
| Equity (Book Value) | 409.85M |
| Book Value Per Share | 6.55 |
| Working Capital | 404.70M |
Full Balance SheetCash Flow
| Operating Cash Flow | -311.09M |
| Capital Expenditures | n/a |
| Free Cash Flow | -311.09M |
| FCF Per Share | -$4.97 |
Full Cash Flow StatementMargins
| Gross Margin | -291.84% |
| Operating Margin | -758.97% |
| Pretax Margin | -747.61% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SAGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.08% |
| Shareholder Yield | -2.08% |
| Earnings Yield | -61.08% |
| FCF Yield | -53.62% |
Dividend DetailsAnalyst Forecast
The average price target for SAGE is $10.06, which is 8.41% higher than the current price. The consensus rating is "Hold".
| Price Target | $10.06 |
| Price Target Difference | 8.41% |
| Analyst Consensus | Hold |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 41.46% |
| EPS Growth Forecast (5Y) | -37.08% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SAGE has an Altman Z-Score of -5.04 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.04 |
| Piotroski F-Score | 1 |
